• Parkinson’s Disease Trials Need Better Markers Of Cognitive Changes

    Clinical Research News | The instruments commonly used to assess cognitive decline in Parkinson’s disease (PD) patients enrolled in neuroprotective clinical trials are “poorly suited to the task,” according to industry consultant Travis Turner, Ph.D., assistant professor and director of the neuropsychology division at Medical University of South Carolina, and senior clinical director for movement disorders at WCG. “I strongly suspect that good interventions have been discarded because [of] the tests that were trying to measure efficacy.”

    May 10, 2023

  • Predictive Analytics Giving The Lowdown on Clinical Trial Performance

    Clinical Research News | A data-agnostic integration platform for optimizing trial planning and conduct hit the streets three years ago, bringing near-real-time insights about every participant, site, country, region, and study to companies struggling to reduce the cost and speed the pace of clinical research. The technology, powered by machine learning, is currently underpinned by data from more than 2,000 trials and over 400,000 healthcare providers.

    May 9, 2023